~20 spots leftby Mar 2026

Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

Recruiting in Palo Alto (17 mi)
Overseen ByTara Brinkman, PhD
Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: St. Jude Children's Research Hospital
Approved in 2 jurisdictions

Trial Summary

What is the purpose of this trial?Long-term survivors of ALL are at-risk for neurocognitive impairment, particularly in the area of executive functioning. Relatively limited research has focused on interventions for improving neurocognitive outcomes in long-term survivors of ALL. A promising technique for cognitive enhancement is Transcranial Direct Current Stimulation (tDCS) which differs from conventional cognitive remediation approaches in that it directly stimulates specific brain regions responsible for cognitive processes and activates functional networks similar to those activated during cognitive training. Primary Objective To evaluate the efficacy of home-based transcranial direct current stimulation (tDCS) paired with remote cognitive training on direct testing of executive function in survivors of ALL. Secondary Objectives * To evaluate the efficacy of home-based transcranial direct current stimulation (tDCS) paired with remote cognitive training on patient-reported symptoms of executive dysfunction in survivors of ALL. * To examine the effects of home-based tDCS paired with remote cognitive training on patterns of regional brain activation as measured by functional magnetic resonance imaging. * To examine the effects of home-based tDCS paired with remote cognitive training on white matter integrity and structure as measured by diffusion tensor imaging.

Eligibility Criteria

Participant Groups

2Treatment groups
Active Control
Placebo Group
Group I: Active tDCSActive Control1 Intervention
Remotely delivered active tDCS + cognitive training
Group II: Sham tDCSPlacebo Group1 Intervention
Remotely delivered sham tDCS + cognitive training
Active tDCS is already approved in United Kingdom, Brazil for the following indications:
๐Ÿ‡ฌ๐Ÿ‡ง Approved in United Kingdom as Transcranial Direct Current Stimulation for:
  • Depression
๐Ÿ‡ง๐Ÿ‡ท Approved in Brazil as Transcranial Direct Current Stimulation for:
  • Depression

Find A Clinic Near You

Research locations nearbySelect from list below to view details:
St. Jude Children's Research HospitalMemphis, TN
Loading ...

Who is running the clinical trial?

St. Jude Children's Research HospitalLead Sponsor
National Cancer Institute (NCI)Collaborator

References